Sinthia Bosnic-Anticevich1,2, Christina Callan3, Henry Chrystyn3,4, Federico Lavorini5, Vasilis Nikolaou3, Vicky Kritikos1, P N Richard Dekhuijzen6, Nicolas Roche7, Leif Bjermer8, Cynthia Rand9, Nicholas Zwar10,11, David B Price3,12. 1. a Woolcock Institute of Medical Research, University of Sydney , Sydney , Australia. 2. b Sydney Local Health District , Sydney , Australia. 3. c Observational and Pragmatic Research Institute Pte. Ltd. , Singapore , Singapore. 4. d Faculty of Health and Human Sciences , Plymouth University, Peninsula Allied Health Centre , Plymouth , UK. 5. e Department of Experimental and Clinical Medicine , Careggi University Hospital , Florence , Italy. 6. f Radboud University Medical Centre , Nijmegen , The Netherlands. 7. g Cochin Hospital (AP-HP), University Paris Descartes (EA2511) , Paris , France. 8. h Lung Medicine and Allergology, Department of Clinical Sciences , Lund University , Lund , Sweden. 9. i Johns Hopkins School of Medicine , Baltimore , Maryland , USA. 10. j University of Wollongong , Wollongong , Australia. 11. k UNSW , Sydney , Australia. 12. l University of Aberdeen , Aberdeen , UK.
Abstract
OBJECTIVE: Healthcare professionals (HCPs) are required to assess and train patients in the correct use of inhalers but are often unable to demonstrate correct technique themselves. We sought to assess the level of training required for HCPs to master and maintain device mastery when using two different dry powder inhalers (DPIs). METHODS: We conducted a randomized, un-blinded, crossover study in undergraduate HCPs who undertook a six-step training procedure (intuitive use, patient information leaflet, instructional video, individual tuition from expert, then two repeats of individual tuition) for the use of Turbuhaler® (an established device) and Spiromax® (a newer device, reportedly easier to use). Device mastery (absence of errors) was evaluated by expert assessors at each training step. Maintenance of mastery was assessed 4 ± 1 week (visit 2) and 8 ± 2 weeks (visit 3) after initial training (visit 1). RESULTS: Of 516 eligible participants, 113 (22%) demonstrated device mastery prior to training on Spiromax® compared with 20 (4%) on Turbuhaler® (p < 0.001). The median number of training steps required to achieve mastery was 2 (interquartile range [IQR] 2-4) for Spiromax® and 3 (IQR 2-4) for Turbuhaler® (p < 0.001). A higher number of participants maintained mastery with Spiromax® compared with Turbuhaler®, at visits 2 and 3 (64% vs 41% and 79% vs 65%, respectively; p < 0.001). CONCLUSIONS: There are significant differences in the nature and extent of training required to achieve and maintain mastery for Spiromax® and Turbuhaler® devices. The implications on clinical practice, device education delivery, and patient outcomes require further evaluation.
RCT Entities:
OBJECTIVE: Healthcare professionals (HCPs) are required to assess and train patients in the correct use of inhalers but are often unable to demonstrate correct technique themselves. We sought to assess the level of training required for HCPs to master and maintain device mastery when using two different dry powder inhalers (DPIs). METHODS: We conducted a randomized, un-blinded, crossover study in undergraduate HCPs who undertook a six-step training procedure (intuitive use, patient information leaflet, instructional video, individual tuition from expert, then two repeats of individual tuition) for the use of Turbuhaler® (an established device) and Spiromax® (a newer device, reportedly easier to use). Device mastery (absence of errors) was evaluated by expert assessors at each training step. Maintenance of mastery was assessed 4 ± 1 week (visit 2) and 8 ± 2 weeks (visit 3) after initial training (visit 1). RESULTS: Of 516 eligible participants, 113 (22%) demonstrated device mastery prior to training on Spiromax® compared with 20 (4%) on Turbuhaler® (p < 0.001). The median number of training steps required to achieve mastery was 2 (interquartile range [IQR] 2-4) for Spiromax® and 3 (IQR 2-4) for Turbuhaler® (p < 0.001). A higher number of participants maintained mastery with Spiromax® compared with Turbuhaler®, at visits 2 and 3 (64% vs 41% and 79% vs 65%, respectively; p < 0.001). CONCLUSIONS: There are significant differences in the nature and extent of training required to achieve and maintain mastery for Spiromax® and Turbuhaler® devices. The implications on clinical practice, device education delivery, and patient outcomes require further evaluation.
Authors: David B Price; Vicky Thomas; P N Richard Dekhuijzen; Sinthia Bosnic-Anticevich; Nicolas Roche; Federico Lavorini; Priyanka Raju; Daryl Freeman; Carole Nicholls; Iain R Small; Erika Sims; Guilherme Safioti; Janice Canvin; Henry Chrystyn Journal: BMC Pulm Med Date: 2018-06-28 Impact factor: 3.317
Authors: Jaco Voorham; Nicolas Roche; Hicham Benhaddi; Marianka van der Tol; Victoria Carter; Job F M van Boven; Leif Bjermer; Marc Miravitlles; David B Price Journal: BMJ Open Date: 2018-10-27 Impact factor: 2.692